Chen Deng

Title: Chen Deng: Innovator in N-Acetylglucosamine Production

Introduction

Chen Deng is a notable inventor based in Taian, China. He has made significant contributions to the field of biotechnology, particularly in the production of N-acetylglucosamine. With a total of 2 patents, his work has the potential to impact various applications in metabolic engineering.

Latest Patents

Chen Deng's latest patents include a RamA transcription factor mutant designed to promote the production of N-acetylglucosamine. This invention details a mutant obtained by mutating lysine at position 90 to asparagine and serine at position 92 to lysine in a parent with a specific amino acid sequence. The genetically engineered strain that overexpresses this mutant significantly increases the production of N-acetylglucosamine, achieving a maximum concentration of 31.5 g/L. This advancement lays a foundation for further metabolic engineering aimed at producing glucosamine. Another patent focuses on a recombinant that produces N-acetylglucosamine by overexpressing the transcription factor SugR. This recombinant increases the production of acetylglucosamine to up to 26 g/L, further supporting metabolic engineering efforts.

Career Highlights

Throughout his career, Chen Deng has worked with reputable institutions such as Jiangnan University and Shandong Runde Biotechnology Co., Ltd. His research and innovations have positioned him as a key figure in the biotechnology sector.

Collaborations

Chen has collaborated with notable coworkers, including Long Liu and Jian Chen. Their combined efforts have contributed to the advancements in the production of N-acetylglucosamine.

Conclusion

Chen Deng's innovative work in the field of biotechnology, particularly in enhancing the production of N-acetylglucosamine, showcases his significant contributions as an inventor. His patents and collaborations reflect a commitment to advancing metabolic engineering and biotechnology applications.